i've been thinking about some theoretical receptor interactions lately, specifically looking at tramadol and mitragynine (white vein kratom) and how they compete at the mu-opioid receptor.
obviously, standard disclaimer first: this is purely a theoretical thought experiment about receptor affinity vs efficacy. if someone is overdosing on tramadol, they need emergency services and naloxone. do not try this in real life.
so here is the theoretical scenario i was putting together. let's say someone is experiencing severe respiratory depression from a tramadol overdose. their mu-opioid receptors in the brain stem are fully saturated by o-dsmt (the full agonist metabolite), which is suppressing their breathing. at the same time, the unmetabolized tramadol is actively blocking the reuptake of serotonin and norepinephrine due to its snri properties.
if a high dose of mitragynine is introduced into this system, we know it has a significantly higher binding affinity for the mu-opioid receptor compared to o-dsmt, but it's only a partial agonist.
my theory is that the mitragynine would competitively displace the o-dsmt from the receptors because of its higher binding affinity. since mitragynine is a partial agonist with a ceiling effect on respiratory depression, this displacement should theoretically reverse the fatal respiratory suppression. it basically acts through the same mechanism buprenorphine does in a clinical overdose setting.
but here is the part i find really interesting about the aftermath. if you use naloxone, the person wakes up in extreme precipitated withdrawal and dysphoria because the opioid receptors are completely stripped bare.
in this mitragynine scenario, the respiratory depression is reversed, but mitragynine doesn't touch the sert or net transporters. the snri blockade from the tramadol is still fully active in the mu-opioid receptor (mor), and white vein kratom has strong alpha-2 adrenergic antagonist properties, which triggers a massive release of norepinephrine.
so theoretically, instead of waking up in hellish withdrawal, the subject would wake up breathing normally, but their brain would be flooded with trapped serotonin and a massive spike of norepinephrine. this would prevent the acute dysphoria and instead cause a sudden wave of extreme cognitive arousal and mood elevation.
does this receptor logic hold up? i'm curious what you guys think about the displacement mechanics here and if the residual snri mechanism would actually act as a psychological safety net to negate the dysphoria of a receptor reversal.
obviously, standard disclaimer first: this is purely a theoretical thought experiment about receptor affinity vs efficacy. if someone is overdosing on tramadol, they need emergency services and naloxone. do not try this in real life.
so here is the theoretical scenario i was putting together. let's say someone is experiencing severe respiratory depression from a tramadol overdose. their mu-opioid receptors in the brain stem are fully saturated by o-dsmt (the full agonist metabolite), which is suppressing their breathing. at the same time, the unmetabolized tramadol is actively blocking the reuptake of serotonin and norepinephrine due to its snri properties.
if a high dose of mitragynine is introduced into this system, we know it has a significantly higher binding affinity for the mu-opioid receptor compared to o-dsmt, but it's only a partial agonist.
my theory is that the mitragynine would competitively displace the o-dsmt from the receptors because of its higher binding affinity. since mitragynine is a partial agonist with a ceiling effect on respiratory depression, this displacement should theoretically reverse the fatal respiratory suppression. it basically acts through the same mechanism buprenorphine does in a clinical overdose setting.
but here is the part i find really interesting about the aftermath. if you use naloxone, the person wakes up in extreme precipitated withdrawal and dysphoria because the opioid receptors are completely stripped bare.
in this mitragynine scenario, the respiratory depression is reversed, but mitragynine doesn't touch the sert or net transporters. the snri blockade from the tramadol is still fully active in the mu-opioid receptor (mor), and white vein kratom has strong alpha-2 adrenergic antagonist properties, which triggers a massive release of norepinephrine.
so theoretically, instead of waking up in hellish withdrawal, the subject would wake up breathing normally, but their brain would be flooded with trapped serotonin and a massive spike of norepinephrine. this would prevent the acute dysphoria and instead cause a sudden wave of extreme cognitive arousal and mood elevation.
does this receptor logic hold up? i'm curious what you guys think about the displacement mechanics here and if the residual snri mechanism would actually act as a psychological safety net to negate the dysphoria of a receptor reversal.
